Evidence map›Paper›PMID 26077254›Full record

ArticleAntimicrobial agents and chemotherapy2015

Impact of ceftiofur injection on gut microbiota and Escherichia coli resistance in pigs.

M A Fleury, G Mourand, E Jouy, F Touzain, L Le Devendec, C de Boisseson, F Eono, R Cariolet, A Guérin, O Le Goff and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Applied and environmental microbiology · 2025
    Article
  5. Dissemination of IncI plasmid encodingAntimicrobial agents and chemotherapy · 2023
    Article
  6. Article
  7. Effect of high-copper diet on transference ofFrontiers in veterinary science · 2023
    Article
  8. Critically Important Antimicrobial Resistance Trends inPathogens (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Impact ofVeterinary and animal science · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

M A FleuryANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France Clermont Université, Université d'Auvergne, Centre de Recherche en Nutrition Humaine-Auvergne, EA 4678 CIDAM, Conception, Ingénierie et Développement de l'Aliment et du Médicament, Clermont-Ferrand, France.
G MourandANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
E JouyANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
F TouzainANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
L Le DevendecANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
C de BoissesonANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
F EonoANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
R CarioletANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France.
A GuérinANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France INRA, UMR408 Sécurité et Qualité des Produits d'Origine Végétale, Avignon, France.
O Le GoffClermont Université, Université d'Auvergne, Centre de Recherche en Nutrition Humaine-Auvergne, EA 4678 CIDAM, Conception, Ingénierie et Développement de l'Aliment et du Médicament, Clermont-Ferrand, France.
S Blanquet-DiotClermont Université, Université d'Auvergne, Centre de Recherche en Nutrition Humaine-Auvergne, EA 4678 CIDAM, Conception, Ingénierie et Développement de l'Aliment et du Médicament, Clermont-Ferrand, France.
M AlricClermont Université, Université d'Auvergne, Centre de Recherche en Nutrition Humaine-Auvergne, EA 4678 CIDAM, Conception, Ingénierie et Développement de l'Aliment et du Médicament, Clermont-Ferrand, France.
I KempfANSES, Laboratoire de Ploufragan-Plouzané, Ploufragan, France Université Européenne de Bretagne, Rennes, France isabelle.kempf@anses.fr.
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRUniversité Européenne de Bretagne · FRUniversité Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to extended-spectrum cephalosporins (ESCs) is an important health concern. Here, we studied the impact of the administration of a long-acting form of ceftiofur on the pig gut microbiota and ESC resistance in Escherichia coli. Pigs were orally inoculated with an ESC-resistant E. coli M63 strain harboring a conjugative plasmid carrying a gene conferring resistance, bla CTX-M-1. On the same day, they were given or not a unique injection of ceftiofur. Fecal microbiota were studied using quantitative PCR analysis of the main bacterial groups and quantification of short-chain fatty acids. E. coli and ESC-resistant E. coli were determined by culture methods, and the ESC-resistant E. coli isolates were characterized. The copies of the bla CTX-M-1 gene were quantified. After ceftiofur injection, the main change in gut microbiota was the significant but transitory decrease in the E. coli population. Acetate and butyrate levels were significantly lower in the treated group. In all inoculated groups, E. coli M63 persisted in most pigs, and the bla CTX-M-1 gene was transferred to other E. coli. Culture and PCR results showed that the ceftiofur-treated group shed significantly more resistant strains 1 and 3 days after ESC injection. Thereafter, on most dates, there were no differences between the groups, but notably, one pig in the nontreated group regularly excreted very high numbers of ESC-resistant E. coli, probably leading to a higher contamination level in its pen. In conclusion, the use of ESCs, and also the presence of high-shedding animals, are important features in the spread of ESC resistance.

Indexed as

AnimalsAnti-Bacterial Agentsbeta-LactamasesCephalosporinsEscherichia coliEscherichia coli InfectionsGastrointestinal MicrobiomeSwineAnti-Bacterial Agentsbeta-Lactamasesbeta-lactamase TEM-3ceftiofurCephalosporins

Identifiers

PMID26077254
PMCPMC4538500
OpenAlexW1915924919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.